CODA Biotherapeutics Announces Preclinical Data From Epilepsy Program to be Presented at American Society of Gene & Cell Therapy 25th Annual Meeting

/PRNewswire/ -- CODA Biotherapeutics, Inc. ("CODA"), a preclinical-stage biopharmaceutical company developing a gene therapy-mediated chemogenetic platform to...

Related Keywords

United States ,Washington ,Americans ,American ,Sprague Dawley ,Michael Narachi ,Edward Yeh ,Centers For Disease ,Epilepsy Foundation ,World Health Organization ,American Society Of Gene Cell Therapy ,Waltere Washington Convention Center ,Journal Of Pain Research ,Biotherapeutics Inc ,National Institute Of Neurological Disorders ,American Society ,Cell Therapy ,Annual Meeting ,Optimal Hippocampal Neuron Expression ,Neurological Diseases ,Board Number ,Droplet Digital ,Focal Epilepsy ,Chronic Neuropathic ,Disease Control ,National Institute ,Neurological Disorders ,Pain Research ,Coda Biotherapeutics ,Nc ,